Yozma

An AI-powered chatbot for hotels revolutionizes the way guests interact with in-room services by enabling seamless cross-selling and upselling. Integrated within smart devices or hotel apps, this AI solution leverages natural language processing (NLP) to communicate with guests in a conversational and personalized manner. From booking spa treatments and restaurant reservations to upgrading rooms or scheduling late checkouts, the chatbot intuitively identifies guest preferences and suggests relevant services. It analyzes data such as guest profiles, previous stays, and real-time behavior to deliver tailored recommendations, boosting both guest satisfaction and revenue. Available 24/7, the chatbot ensures instant responses to guest inquiries, reducing dependence on front-desk staff and enhancing operational efficiency. Additionally, it supports multiple languages, catering to a global clientele and making communication barrier-free. Hotels can integrate the AI chatbot with their property management systems (PMS) and point-of-sale (POS) platforms to streamline service delivery and track guest interactions. The solution empowers hotels to provide a hyper-personalized, tech-forward experience, which appeals to modern travelers. By automating cross-selling and upselling opportunities while improving guest engagement, the chatbot not only enhances the overall stay experience but also drives incremental revenue, making it a vital tool for the hospitality industry.

Meat.The End is focused on advancing plant-based meat alternatives that closely replicate the texture, flavor, and appearance of traditional animal proteins. By employing innovative extrusion processing techniques, the company develops protein texturizing technologies that enhance the sensory experience of plant-based products. Recognizing that texture remains a significant barrier to consumer acceptance of meat alternatives, Meat.The End's solutions aim to improve the mouthfeel and overall eating experience, thereby addressing a critical shortcoming in current plant-based offerings. Through its industrial processes and protein treatment methods, the company enables producers to create nutritionally balanced products that convincingly mimic the characteristics of meat, ultimately providing healthier and more satisfying options for consumers seeking alternatives to animal-based foods.

Meat.The End is focused on advancing plant-based meat alternatives that closely replicate the texture, flavor, and appearance of traditional animal proteins. By employing innovative extrusion processing techniques, the company develops protein texturizing technologies that enhance the sensory experience of plant-based products. Recognizing that texture remains a significant barrier to consumer acceptance of meat alternatives, Meat.The End's solutions aim to improve the mouthfeel and overall eating experience, thereby addressing a critical shortcoming in current plant-based offerings. Through its industrial processes and protein treatment methods, the company enables producers to create nutritionally balanced products that convincingly mimic the characteristics of meat, ultimately providing healthier and more satisfying options for consumers seeking alternatives to animal-based foods.

Fine Data Lab is a digital data analysis company offering digital marketing consulting, analytics, and data analytics solutions.

Illumigyn incorporates existing machine vision technologies into a compact imaging colposcope for medical applications in an effort to eliminate the inherent subjectivity of cervical exams. Its Gynescope is a patented imaging colposcope that delivers 15-micron image resolution over a wide field of view and a range of working distances. The Gynescope also has multispectral illumination options, allowing early detection of cervical cancer while meaningfully reducing misdiagnoses. The Gynescope enables sophisticated imaging with simultaneous complex interventional procedures to support the best clinical outcomes.

OP.GG is an e-gaming data analytics company that focuses on enhancing the gaming experience for players by creating detailed profiles based on their gameplay data. The platform supports popular games such as League of Legends, Overwatch, and PUBG, enabling users to analyze their own performance as well as that of their opponents and friends. With a user base exceeding 28 million monthly, OP.GG provides valuable insights that help gamers improve their skills and navigate the competitive landscape more effectively. The company's mission is to foster a better gaming ecosystem by equipping players with the tools they need to succeed.

UltraSight is a company focused on enhancing cardiac care through an artificial intelligence-powered ultrasound system. Its technology is designed to assist ultrasound operators in capturing high-quality images more efficiently, thereby facilitating quicker and more accurate diagnoses and treatments for heart disease. By making ultrasound accessible in various healthcare settings, UltraSight aims to improve the quality and timeliness of clinical decisions for patients. The company's innovative approach has gained recognition, winning the TCT 2020 Innovation Competition at the Transcatheter Cardiovascular Therapeutics world conference.

Todos Medical Ltd is an in vitro diagnostics company focused on developing tests for various medical conditions, including breast cancer, Alzheimer's disease, and COVID-19. The company operates primarily in the United States and generates all its revenue from this market. The strength of Todos Medical lies in its multidisciplinary team, which comprises experts in medicine, physics, biochemistry, digital signal processing, and electrical engineering. This diverse expertise provides the company with a competitive advantage in the diagnostics field.

Nanox Imaging is a Gibraltar-based company founded in 2011 that specializes in advanced imaging technology for medical, security, and telecommunications applications. The company is pioneering next-generation X-ray emitters utilizing innovative nanotechnology to modernize X-ray imaging, enabling the development of novel 3D imaging systems with superior performance. Central to Nanox's offerings is the Nanox System, which provides a preventative healthcare service known as Medical Screening As A Service (MSaaS). The company has leveraged over two decades of research and development, investing more than $1 billion to create proprietary cold cathode technology that enhances X-ray imaging capabilities. This technology features a chip composed of nano-scale structures, designed through unique nanofabrication techniques, which supports various medical imaging applications and is complemented by additional technologies to maximize its practical benefits in real-world scenarios.

UltraSight is a company focused on enhancing cardiac care through an artificial intelligence-powered ultrasound system. Its technology is designed to assist ultrasound operators in capturing high-quality images more efficiently, thereby facilitating quicker and more accurate diagnoses and treatments for heart disease. By making ultrasound accessible in various healthcare settings, UltraSight aims to improve the quality and timeliness of clinical decisions for patients. The company's innovative approach has gained recognition, winning the TCT 2020 Innovation Competition at the Transcatheter Cardiovascular Therapeutics world conference.

BiSiChem is a biotechnology company dedicated to drug discovery and development, with a particular emphasis on immuno-oncology and central nervous system therapies. The company conducts research to identify molecular drug targets, primarily focusing on anti-cancer agents and treatments for Alzheimer’s dementia. By developing targeted therapies and immunosuppressive drugs, BiSiChem aims to provide innovative, first-in-class treatment options for patients suffering from cancer and neurodegenerative diseases.

NextNine is a leader in Operational Technology (OT) security management software for industrial and critical infrastructure, markets that are vulnerable to cyber security attacks and are underserved by conventional enterprise IT solutions. Using NextNine you can have centralized OT security management for your entire SCADA/ICS environment. Distributed critical infrastructure plants and facilities with proprietary ICS/SCADA networks and devices, paired with the need for external vendors to provide remote maintenance and support, create an ideal target profile for hackers and terrorist attacks. Traditional IT security management solutions were designed to manage standard computing environments and cannot handle the proprietary processes, networks and devices of the ICS/SCADA world. In contrast, NextNine has over 10 years of leadership in OT security, and has purpose-built its product to deal with these unique challenges. NextNine’s solution is an industrial strength software platform delivering robust, customizable and field proven OT security management. Top tier critical infrastructure companies along with 5 of the 7 largest industrial vendors have standardized on NextNine. Today, the company has 6000 installations globally in fields such as oil, gas, mining, chemicals, energy, manufacturing, defense and critical infrastructure. NextNine has been recognized by the White House for its leadership in the efforts to improve critical infrastructure cyber security. NextNine has received ISO/IEC 27001:2013 certification, assuring NextNine's employees operate a comprehensive security program and manage information security risks effectively. NextNine's certificate is issued by the Standards Institution of Israel. The company was founded in 1998, is privately held and headquartered in New York.

Kailight Photonics develops optical modules for the telecommunications industry. It offers tunable optical signal regenerator, an optical component that operates with regenerators, optical switches, add/drop multiplexers, and cross-connects. The company's optical transmission, signal regeneration, and wavelength conversion technology provides optical-networking solutions for systems vendors. It provides its products to long-haul network market segments. The company, formerly known as Chilight Technologies, was founded in 2000 and is headquartered in Rehovot, Israel with an additional office in Dallas, Texas. As of May 15, 2007, Kailight Photonics, Inc. operates as a subsidiary of Optium Corporation.

CogniTens, Ltd. specializes in advanced three-dimensional optical measurement solutions for the automotive and manufacturing industries. The company offers a range of products, including Optigo, a portable platform for dimensional measurement, and OptiCell, an automated system for off-line recurring measurements on the production floor. Additionally, CogniTens provides software solutions such as CoreView Plan for developing measurement programs, CoreView Pro for analyzing and reporting measurement data, and CoreView Lite for viewing results. Their offerings facilitate industrial engineering activities, including tooling, part production, assembly, quality assurance, and process control. Founded in 1995 and headquartered in Ramat Hasharon, Israel, CogniTens serves automotive original equipment manufacturers, tier-one suppliers, tool and die companies, and other engineering organizations through a network of distributors.

Predix Pharmaceuticals is a drug discovery and development company specializing in small-molecule drugs that target G-protein coupled receptors (GPCRs) and ion channels. The company employs an innovative 3D Discovery and Optimization Engine that utilizes a proprietary algorithm for computer modeling the 3D structures of GPCR targets. Its advanced technologies enable high-throughput in silico screening of millions of compounds against these models, facilitating lead optimization through an integrated medicinal and computational platform. Predix's drug candidates are aimed at treating various conditions, including anxiety, Alzheimer's disease, and pulmonary arterial hypertension. In August, the company expanded its capabilities in drug discovery through a merger with Physiome Sciences Inc., enhancing its expertise in ion channel research.

NextNine is a leader in Operational Technology (OT) security management software for industrial and critical infrastructure, markets that are vulnerable to cyber security attacks and are underserved by conventional enterprise IT solutions. Using NextNine you can have centralized OT security management for your entire SCADA/ICS environment. Distributed critical infrastructure plants and facilities with proprietary ICS/SCADA networks and devices, paired with the need for external vendors to provide remote maintenance and support, create an ideal target profile for hackers and terrorist attacks. Traditional IT security management solutions were designed to manage standard computing environments and cannot handle the proprietary processes, networks and devices of the ICS/SCADA world. In contrast, NextNine has over 10 years of leadership in OT security, and has purpose-built its product to deal with these unique challenges. NextNine’s solution is an industrial strength software platform delivering robust, customizable and field proven OT security management. Top tier critical infrastructure companies along with 5 of the 7 largest industrial vendors have standardized on NextNine. Today, the company has 6000 installations globally in fields such as oil, gas, mining, chemicals, energy, manufacturing, defense and critical infrastructure. NextNine has been recognized by the White House for its leadership in the efforts to improve critical infrastructure cyber security. NextNine has received ISO/IEC 27001:2013 certification, assuring NextNine's employees operate a comprehensive security program and manage information security risks effectively. NextNine's certificate is issued by the Standards Institution of Israel. The company was founded in 1998, is privately held and headquartered in New York.

CogniTens, Ltd. specializes in advanced three-dimensional optical measurement solutions for the automotive and manufacturing industries. The company offers a range of products, including Optigo, a portable platform for dimensional measurement, and OptiCell, an automated system for off-line recurring measurements on the production floor. Additionally, CogniTens provides software solutions such as CoreView Plan for developing measurement programs, CoreView Pro for analyzing and reporting measurement data, and CoreView Lite for viewing results. Their offerings facilitate industrial engineering activities, including tooling, part production, assembly, quality assurance, and process control. Founded in 1995 and headquartered in Ramat Hasharon, Israel, CogniTens serves automotive original equipment manufacturers, tier-one suppliers, tool and die companies, and other engineering organizations through a network of distributors.

Can-Fite BioPharma (TASE:CFBI; NYSE MKT:CANF) is an Israeli biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities. The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory and cancer diseases.

Predix Pharmaceuticals is a drug discovery and development company specializing in small-molecule drugs that target G-protein coupled receptors (GPCRs) and ion channels. The company employs an innovative 3D Discovery and Optimization Engine that utilizes a proprietary algorithm for computer modeling the 3D structures of GPCR targets. Its advanced technologies enable high-throughput in silico screening of millions of compounds against these models, facilitating lead optimization through an integrated medicinal and computational platform. Predix's drug candidates are aimed at treating various conditions, including anxiety, Alzheimer's disease, and pulmonary arterial hypertension. In August, the company expanded its capabilities in drug discovery through a merger with Physiome Sciences Inc., enhancing its expertise in ion channel research.

HyWire deals with the need for speed and capacity over the Internet. The demand for bandwidth is increasing exponentially mainly due to the number of users and the network applications (video, voice over IP, e-commerce and various enterprise applications).

NextNine is a leader in Operational Technology (OT) security management software for industrial and critical infrastructure, markets that are vulnerable to cyber security attacks and are underserved by conventional enterprise IT solutions. Using NextNine you can have centralized OT security management for your entire SCADA/ICS environment. Distributed critical infrastructure plants and facilities with proprietary ICS/SCADA networks and devices, paired with the need for external vendors to provide remote maintenance and support, create an ideal target profile for hackers and terrorist attacks. Traditional IT security management solutions were designed to manage standard computing environments and cannot handle the proprietary processes, networks and devices of the ICS/SCADA world. In contrast, NextNine has over 10 years of leadership in OT security, and has purpose-built its product to deal with these unique challenges. NextNine’s solution is an industrial strength software platform delivering robust, customizable and field proven OT security management. Top tier critical infrastructure companies along with 5 of the 7 largest industrial vendors have standardized on NextNine. Today, the company has 6000 installations globally in fields such as oil, gas, mining, chemicals, energy, manufacturing, defense and critical infrastructure. NextNine has been recognized by the White House for its leadership in the efforts to improve critical infrastructure cyber security. NextNine has received ISO/IEC 27001:2013 certification, assuring NextNine's employees operate a comprehensive security program and manage information security risks effectively. NextNine's certificate is issued by the Standards Institution of Israel. The company was founded in 1998, is privately held and headquartered in New York.

Predix Pharmaceuticals is a drug discovery and development company specializing in small-molecule drugs that target G-protein coupled receptors (GPCRs) and ion channels. The company employs an innovative 3D Discovery and Optimization Engine that utilizes a proprietary algorithm for computer modeling the 3D structures of GPCR targets. Its advanced technologies enable high-throughput in silico screening of millions of compounds against these models, facilitating lead optimization through an integrated medicinal and computational platform. Predix's drug candidates are aimed at treating various conditions, including anxiety, Alzheimer's disease, and pulmonary arterial hypertension. In August, the company expanded its capabilities in drug discovery through a merger with Physiome Sciences Inc., enhancing its expertise in ion channel research.

Globecom Interactive Ltd. is a pioneering developer of enterprise, end-to-end broadband solutions for the creation, management, and delivery of rich dynamic media over multiple platforms. They provide software solutions enabling businesses to maximize the productivity of new and established Internet market channels.

Compugen Ltd. is a clinical-stage therapeutic discovery and development company based in Holon, Israel, focused on immuno-oncology. The company leverages its advanced computational discovery capabilities to identify novel drug targets and biological pathways, leading to the development of therapeutics for cancer treatment. Compugen's immuno-oncology pipeline includes several clinical-stage programs, such as COM701, an anti-PVRIG antibody, and COM902, a therapeutic antibody targeting TIGIT, both of which are in Phase I clinical studies for solid tumors. Additionally, the company is exploring early-stage programs aimed at addressing various mechanisms of immune resistance. Compugen has established collaborations with notable organizations, including Bayer Pharma AG and Bristol-Myers Squibb, for the research and development of antibody-based therapeutics. The company's innovative approach combines in silico prediction with experimental validation, allowing it to address critical therapeutic and diagnostic needs in the pharmaceutical and biotech sectors. Compugen was incorporated in 1993 and continues to advance its research and development efforts in the field of cancer immunotherapy.

Cardonet is a provider of IT support and technology services, dedicated to maximizing revenue and supporting business growth. Founded in 1999, the company offers a comprehensive range of managed IT services, including assistance with forgotten passwords, server emergencies, office relocations, and data center design. Cardonet's commitment to ensuring smooth IT operations is evident in its hands-on approach, with directors often directly engaging with clients to deliver solutions. The company also enables e-marketplaces to create and maintain transactive catalogs, enhancing the buyer's experience and increasing marketplace transactions. Through its focus on effective technology use, Cardonet aims to help businesses gain a competitive advantage in their respective industries.

HarmonyCom is a privately held, venture-backed telecommunications software solutions provider founded in 1997. It has its U.S. headquarters in Ann Arbor, Michigan with operations in London and Tel Aviv. The lead investor in HarmonyCom is Iscal Holdings, Ltd., a private Israeli investment company that focuses on emerging high-tech companies. Additional funding has been received from Yozma Venture Capital. HarmonyCom's premier product is Harmony, a software solution that automates and orchestrates the delivery of broadband data services, allowing for measurable improvements in customer satisfaction, faster time-to-market for new products, reduced operational costs, and improved accuracy of information.

Telegate is a developer of the most reliable and feature-rich VoIP system.

NextNine is a leader in Operational Technology (OT) security management software for industrial and critical infrastructure, markets that are vulnerable to cyber security attacks and are underserved by conventional enterprise IT solutions. Using NextNine you can have centralized OT security management for your entire SCADA/ICS environment. Distributed critical infrastructure plants and facilities with proprietary ICS/SCADA networks and devices, paired with the need for external vendors to provide remote maintenance and support, create an ideal target profile for hackers and terrorist attacks. Traditional IT security management solutions were designed to manage standard computing environments and cannot handle the proprietary processes, networks and devices of the ICS/SCADA world. In contrast, NextNine has over 10 years of leadership in OT security, and has purpose-built its product to deal with these unique challenges. NextNine’s solution is an industrial strength software platform delivering robust, customizable and field proven OT security management. Top tier critical infrastructure companies along with 5 of the 7 largest industrial vendors have standardized on NextNine. Today, the company has 6000 installations globally in fields such as oil, gas, mining, chemicals, energy, manufacturing, defense and critical infrastructure. NextNine has been recognized by the White House for its leadership in the efforts to improve critical infrastructure cyber security. NextNine has received ISO/IEC 27001:2013 certification, assuring NextNine's employees operate a comprehensive security program and manage information security risks effectively. NextNine's certificate is issued by the Standards Institution of Israel. The company was founded in 1998, is privately held and headquartered in New York.